Medication affordability
Reducing financial burdens
Making medications more affordable
No patient should be prevented from starting a life-changing therapy by the cost of medication. Through AmerisourceBergen's commercial copay assistance solutions, patient assistance programs, and free-goods pharmacy services, we reduce patients' financial burdens to elevate access and improve adherence.
Affordability solutions for better patient outcomes
Commercial copay assistance
Data-driven recommendations
Copay accumulators
Our expert team utilizes exposure modeling and strategic intelligence to help manufacturers model, plan, and implement necessary and timely program changes as a result of payer-managed copay accumulators. In addition, we've added copay accumulator impacts as an attribute to our robust benefit verification process and enhanced our reporting to provide the best recommendations.
Dedicated to evolving support
Patient assistance programs
Reducing the growing cost burden patients face requires insulating your program from risk and deploying the right mix of talent and technology. That's why we combine innovative eServices with unmatched expertise. Seasoned counselors provide individualized support while electronic portals facilitate enrollment, eligibility, and renewal. Electronic PAP (ePAP) services allow for automated eligibility checks and determinations in less than a minute. To ensure compliance and mitigate risk, we provide real-time income validation, manage complex eligibility criteria, and monthly reporting on PAP enrollees.
Beyond medication affordability
Biopharma Services
Each investment we make is focused on connecting healthcare stakeholders to accelerate healthier futures. Our unrivaled expertise powers us in our vision to help you fully realize your product’s power—through the patients it reaches and the strategic outcomes it delivers. Learn more about our end to end suite of commercialization solutions for biopharma companies.
Let's work together to envision new paths to healthier futures around the world.